Home

Michael W McCormick

CIK 1333527 · EVP/Global Sales & Marketing · last filed 2023-02-23

Michael W McCormick is an EVP/Global Sales & Marketing who has filed 42 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for CATX, was dated Feb 23, 2023. Across all open-market trades the lifetime net is −$3.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.84M

Companies

3

Total Filings

42

Lifetime Open-Market Net

-$3.82M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CATX Director — $2.95 — $0 1 2023-02-23
Perspective Therapeutics, Inc. (ISR) Delisted Director 41,230 $0.38 $15.8K $29.1K 12 2022-07-29
COLM EVP/Global Sales & Marketing 110,782 $61.73 $6.84M -$3.85M 29 2012-08-13

Recent Filings

42 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-02-23 CATX Grant (A) — $0 EDGAR
2022-07-29 Perspective Therapeutics, Inc. (ISR) Delisted Grant (A) — $0 EDGAR
2021-07-06 Perspective Therapeutics, Inc. (ISR) Delisted Grant (A) — $0 EDGAR
2020-10-28 Perspective Therapeutics, Inc. (ISR) Delisted Buy (P) +19,230 $10.0K EDGAR
2020-07-15 Perspective Therapeutics, Inc. (ISR) Delisted Grant (A) — $0 EDGAR
2019-06-24 Perspective Therapeutics, Inc. (ISR) Delisted Grant (A) — $0 EDGAR
2018-07-25 Perspective Therapeutics, Inc. (ISR) Delisted Grant (A) — $0 EDGAR
2018-07-02 Perspective Therapeutics, Inc. (ISR) Delisted Grant (A) — $0 EDGAR
2017-06-29 Perspective Therapeutics, Inc. (ISR) Delisted Grant (A) — $0 EDGAR
2017-06-29 Perspective Therapeutics, Inc. (ISR) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 42
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.